High materiality7/10
Argus Upgrades Moderna (MRNA) to Buy
Why it may matterVerify against the original reporting
Upgrade signals strong upside potential and favorable risk-reward.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Argus Research upgrades Moderna to Buy; Target $180; current price $142.77.
- Target: $180
- Current price: $142.77
- Firm: Argus Research
Key facts
- 01
Target: $180
- 02
Posted price: $142.77
- 03
Analyst firm: Argus Research
- 04
Analyst: John Eade
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.